NCT00281970View on ClinicalTrials.gov

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2009

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

docetaxel

PROCEDURE

adjuvant therapy

Trial Locations (3)

10021

Memorial Sloan-Kettering Cancer Center, New York

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

37232-6307

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00281970 - Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery | Biotech Hunter | Biotech Hunter